Page last updated: 2024-11-11

eupalmerin acetate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

eupalmerin acetate: cyclic diterpenoid from gorgonians of the Eunicea genus; RN given refers to (1aR-(1aR*,4E,9S*,10R*,13aS*,14R*))-isomer; RN for cpd without isomeric designation not avail 9/93; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5459169
CHEMBL ID1986885
MeSH IDM0220001

Synonyms (5)

Synonym
nsc-637469
eupalmerin acetate
NSC637469 ,
CHEMBL1986885
[(1s,3r,5r,8e,13s,14r,15r)-5,9,13-trimethyl-18-methylidene-17-oxo-4,16-dioxatricyclo[13.3.0.03,5]octadec-8-en-14-yl] acetate

Research Excerpts

Overview

Eupalmerin acetate (EPA) is a marine diterpene compound isolated from the gorgonian octocorals Eunicea succinea and E Unicea mammosa.

ExcerptReferenceRelevance
"Eupalmerin acetate (EPA) is a marine diterpene compound isolated from the gorgonian octocorals Eunicea succinea and Eunicea mammosa. "( Mechanisms of potentiation of the mammalian GABAA receptor by the marine cembranoid eupalmerin acetate.
Akk, G; Eterović, VA; Evers, AS; Li, P; Manion, BD; Reichert, DE; Rodríguez, AD; Steinbach, JH, 2008
)
2.01

Dosage Studied

ExcerptRelevanceReference
" ACh dose-response curves suggested that his inhibition was noncompetitive."( Diterpenoids from Caribbean gorgonians act as noncompetitive inhibitors of the nicotinic acetylcholine receptor.
Eterović, VA; Ferchmin, PA; Hann, RM; Lee, YH; Li, L; McNamee, MG; Rodriguez, AD, 1993
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (42.86)18.2507
2000's3 (42.86)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.24

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.24 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.24)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]